BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2011-01-01 to 2011-12-31
Filed
2012-11-15
IRS object ID
201243209349304334
Schema version
2011v1.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2012-11-15T12:51:34-06:00Timestamp
Tax Period End Date2011-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN410746749EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line14250 N FAIRFAX DRIVE SUITE 1020AddressLine1
CityARLINGTONCity
StateVAState
ZIP Code22203ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INDUSTRY ORGANIZATIONBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlBIOTNameControl
Phone2029629200Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameJOANNE M DUNCANName
TitleCFO & VP FINANCE & ADMINTitle
Phone2029629200Phone
Date Signed2012-11-15DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameKAREN GRIESName
PTINP00078514PTIN
Phone5712279500Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonJAMES C GREENWOODNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode
FieldValueIRS element (for citing)
Gross Receipts77123142GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501cXOrganization501c
Web SiteWWW.BIO.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1993YearFormation
State Legal DomicileDCStateLegalDomicile
Activity Or Mission DescriptionBIOTECHNOLOGY RESEARCHERS EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND BY PROVIDING BETTER HEATHCARE, ENHANCED AGRICULTURE, AND A CLEANER AND SAFER ENVIRONMENT. THE MISSION OF BIO IS TO BE THE CHAMPION OF BIOTECHNOLOGY AND THE ADVOCATE FOR ITS MEMBER ORGANIZATIONS - BOTH LARGE AND SMALL.ActivityOrMissionDescription
Nbr Voting Members Governing Body116NbrVotingMembersGoverningBody
Nbr Independent Voting Members116NbrIndependentVotingMembers
Total Nbr Employees184TotalNbrEmployees
Total Nbr Volunteers196TotalNbrVolunteers
Total Gross UBI333346TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year0ContributionsGrantsPriorYear
Contributions Grants Current Year0ContributionsGrantsCurrentYear
Program Service Revenue Prior Year57498909ProgramServiceRevenuePriorYear
Program Service Revenue CY59284196ProgramServiceRevenueCY
Investment Income Prior Year3478235InvestmentIncomePriorYear
Investment Income Current Year1994532InvestmentIncomeCurrentYear
Other Revenue Prior Year42100OtherRevenuePriorYear
Other Revenue Current Year3900OtherRevenueCurrentYear
Total Revenue Prior Year61019244TotalRevenuePriorYear
Total Revenue Current Year61282628TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year0GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY0GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year23396161SalariesEtcPriorYear
Salaries Etc Current Year25311029SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year0TotalFundrsngExpCurrentYear
Other Expense Prior Year35354014OtherExpensePriorYear
Other Expenses Current Year35650393OtherExpensesCurrentYear
Total Expenses Prior Year58750175TotalExpensesPriorYear
Total Expenses Current Year60961422TotalExpensesCurrentYear
Revenues Less Expenses Prior Year2269069RevenuesLessExpensesPriorYear
Revenues Less Expenses CY321206RevenuesLessExpensesCY
Total Assets BOY65414013TotalAssetsBOY
Total Assets EOY65857637TotalAssetsEOY
Total Liabilities BOY26464995TotalLiabilitiesBOY
Total Liabilities EOY27777267TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY38949018NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY38080370NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionTHE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) REPRESENTS MORE THAN 1,100 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIOTECHNOLOGY INDUSTRY ORGANIZATION IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIOTECHNOLOGY INDUSTRY ORGANIZATION MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIOTECHNOLOGY INDUSTRY ORGANIZATION'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
DescriptionADVOCACYBIO'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2011 ARE LISTED BELOW. - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT ETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANT TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE EMERGING COMPANIES SECTION ADVOCATES FOR POLICIES SUPPORTIVE OF SMALL INNOVATIVE COMPANIES IN AREAS SUCH AS TAX POLICY, FINANCIAL REPORTING AND ACCOUNTING LAW AND REGULATIONS, AND FEDERAL GRANTS. THE EMERGING COMPANIES SECTION'S 2011 ADVOCACY ACCOMPLISHMENTS ARE LISTED BELOW.- ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- INCREASED OPPORTUNITIES FOR SMALL COMPANIES TO RECEIVE FEDERAL GRANTS.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS.- INFLUENCED HEALTH CARE POLICY TO REFLECT THE CONCERNS OF SMALL BIOTECHNOLOGY COMPANIES.THE FOOD & AGRICULTURE SECTION FOCUSES ON MAINTAINING A SCIENCE-BASED REGULATORY ENVIRONMENT FOR BIOTECH CROPS AND EMERGING PRODUCTS, SUCH AS PLANT- AND ANIMAL-MADE PHARMACEUTICALS AND FEEDSTOCKS FOR BIOFUELS. SOME OF THE FOOD AND AGRICULTURE SECTION'S 2011 ADVOCACY ACCOMPLISHMENTS ARE LISTED BELOW. - MOUNTED AN INITIATIVE, IN CONJUNCTION WITH ACADEMIC SCIENTISTS, TO OPPOSE EPA'S PROPOSED DATA REQUIREMENTS RULE AND CONVINCE EPA OF ITS DETRIMENTAL IMPACTS ON BIOTECHNOLOGY INNOVATION. - DEFENDED SCIENCE-BASED REVIEW OF GENETICALLY-ENGINEERED ANIMAL AGAINST LEGISLATIVE CHALLENGES IN APPROPRIATIONS PROCESS AND IN OTHER LEGISLATIVE AND REGULATORY VENUES, IN COORDINATION WITH ALLIED ANIMAL AGRICULTURE ORGANIZATIONS. - CONTINUED EDUCATION OF MEDIA AND POLICYMAKERS ON THE IMPORTANCE OF ANIMAL BIOTECHNOLOGY TO ENHANCE HUMAN AND ANIMAL HEALTH APPLICATIONS, FOOD PRODUCTION AND ENVIRONMENTAL SUSTAINABILITY; REVISED AND RE-PRINTED BIO'S REPORT, GENETICALLY ENGINEERED ANIMALS AND PUBLIC HEALTH, TO USE AS A HARD COPY AND WEB-BASED RESOURCE. - FOSTERED CONGRESSIONAL SUPPORT FOR THE FOOD AND AGRICULTURE SECTION'S KEY FEDERAL SPENDING PRIORITIES, SUCH AS FUNDING FOR APHIS-BRS, USDA'S OFFICE OF GENERAL COUNSEL, AGRICULTURAL ENERGY PRIORITIES, AGRICULTURAL RESEARCH PRIORITIES, FOOD SAFETY INSPECTION SERVICE, AND ANIMAL BIOTECHNOLOGY. - MITIGATED ATTACKS FROM ANTI-BIOTECH GROUPS WITH PROACTIVE WEB-BASED BENEFITS MESSAGING AND MEDIA OUTREACH, AS WELL AS EMPHASIZING THE IMPORTANCE OF TECHNOLOGY TO PRODUCTION AGRICULTURE AND MAINTAINING A RISK-BASED APPROACH TO FOOD LABELING POLICY.THE HEALTH SECTION DRIVES ADVOCACY TO ENSURE THAT PATIENTS HAVE ACCESS TO THE FRUITS OF BIOTECH RESEARCH, WHILE THE MARKETPLACE REWARDS THAT DRIVE CONTINUED INNOVATION ARE MAINTAINED. BELOW ARE THE HEALTH SECTION'S 2011 ACCOMPLISHMENTS.- INFLUENCED IMPROVEMENTS TO THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- ENHANCED PATIENT ACCESS TO INNOVATIVE THERAPIES.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY AND PROMOTE BIOMEDICAL INNOVATION.- PROMOTED DEVELOPMENT AND USE OF RESEARCH TOOLS, MOLECULAR DIAGNOSTICS AND PERSONALIZED THERAPIES. - ADVOCATED FOR POLICIES THAT FOSTER VACCINE INNOVATION AND PROMOTE PANDEMIC AND BIO-DEFENSE PREPAREDNESS.- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION.THE INDUSTRIAL & ENVIRONMENTAL SECTION ADVOCATES FOR INCENTIVES THAT HELP CREATE MARKET DEMAND FOR CUTTING-EDGE CONSUMER PRODUCTS SUCH AS PLANT-BASED PLASTICS AND RENEWABLE FUELS AND CHEMICALS. BELOW ARE THE INDUSTRIAL & ENVIRONMENTAL SECTION'S 2011 ADVOCACY ACCOMPLISHMENTS.RENEWABLE FUEL STANDARD- SUCCESSFULLY ADVOCATED FOR AGGRESSIVE CELLULOSIC GALLON REQUIREMENTS UNDER EPA'S FINAL 2012 RFS RULE.TAX- SUCCESSFULLY ADVOCATED FOR THE INTRODUCTION OF SEVERAL FAVORABLE PIECES OF TAX LEGISLATION RELATING TO ALGAL, CELLULOSIC AND OTHER ADVANCED BIOFUELS.MILITARY USE- SECURED SUPPORT FOR $510 MILLION MULTI-AGENCY PLAN TO ACCELERATE COMMERCIALIZATION OF ADVANCED DROP-IN BIOFUELS FOR MILITARY USE.FARM BILL- SECURED STRONG ENERGY TITLE IN FARM BILL PROPOSALS IN CONGRESS. SYNTHETIC BIOLOGY- ADVOCATED REGARDING THE PROPER REGULATORY APPROACH IN THE EMERGING FIELD OF SYNTHETIC BIOLOGY.BIOBASED PRODUCTS & RENEWABLE SPECIALTY CHEMICALS- ADVOCATED FOR THE CERTIFICATION PROCESS FOR THE VOLUNTARY LABELING PROGRAM IN USDA'S BIOPREFERRED PROGRAM.- ADVOCATED FOR A PRODUCTION TAX CREDIT FRAMEWORK IN CONGRESS.CONFERENCES- BIO HELD TWO INDUSTRIAL BIOTECH CONFERENCES IN 2011-THE BIO WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY AND BIOPROCESSING AND THE BIO PACIFIC RIM SUMMIT ON INDUSTRIAL BIOTECHNOLOGY AND BIOENERGY.Description

Activity2 Activity2

FieldValueIRS element (for citing)
DescriptionSERVICESBIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO PROFESSIONAL DEVELOPMENT CONFERENCES FOR HUMAN RESOURCES AND BUSINESS DEVELOPMENT EXECUTIVES. BIO INTERNATIONAL CONVENTION - THE 2011 BIO INTERNATIONAL CONVENTION WAS HELD IN WASHINGTON, D.C., ON JUNE 27-30, 2011. THE EVENT ATTRACTED 15,626 ATTENDEES FROM 65 COUNTRIES, AND 48 U.S. STATES, INCLUDING 400 MEMBERS OF THE MEDIA. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. 2011 BIO PARTICIPANTS INCLUDED 11 U.S. GOVERNORS, 75 HIGH-LEVEL PUBLIC OFFICIALS, AND LEADERS FROM U.S. CONGRESSIONAL STAFF AND REGULATORY AGENCIES.THE CONVENTION CONTINUED TO DRAW OVER 1/3 (33%+) OF THE ATTENDANCE FROM COUNTRIES OUTSIDE THE U.S.; WHICH INCLUDES MORE THAN 100 INTERNATIONAL PUBLIC OFFICIALS FROM 24 COUNTRIES, INCLUDING MINISTERS OF SCIENCE, AGRICULTURE, AND TECHNOLOGY AND AMBASSADORS FROM COUNTRIES SUCH AS BELGIUM, CANADA, DENMARK, HUNGARY, IRELAND, ISRAEL, MALAYSIA, NETHERLANDS, NEW ZEALAND, RUSSIAN EMBASSY AND SWITZERLAND.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION WERE:- EDUCATIONAL PROGRAMMING THAT INCLUDED 4 DAYS OF 125 BREAKOUT SESSIONS, 15 EDUCATIONAL TRACKS, MORE THAN 800 SPEAKERS, 2 KEYNOTE SESSIONS, AND 6 SUPER SESSIONS.- THE BIO BUSINESS FORUM, WHICH PROVIDED AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS AND INVESTORS FROM AROUND THE WORLD TO SCHEDULE ONE-ON-ONE MEETINGS AND DISCUSS POTENTIAL BUSINESS OPPORTUNITIES; IT HOSTED A RECORD NUMBER OF 21,183 PARTNERING MEETINGS BETWEEN 2,410 COMPANIES AND 157 COMPANY PRESENTATIONS SCHEDULED DURING THE CONVENTION.- THE BIO EXHIBITION HOSTED APPROXIMATELY 1,800 EXHIBITORS WITH 180,000 NET SQUARE FEET OF EXHIBIT SPACE. ATTENDEES MINGLED AMONG THE 61 STATE, COUNTRY AND REGIONAL PAVILIONS AND THE 6 PRODUCT FOCUS ZONES.- PROFESSIONAL NETWORKING TOOK PLACE THROUGHOUT THE CONVENTION DURING 3 LARGE GENERAL EVENTS, AS WELL AS NUMEROUS SMALLER RECEPTIONS. CAPITAL FORMATION & BUSINESS DEVELOPMENT - THROUGH A PORTFOLIO OF EVENTS, BIO SUPPORTS THE CAPITAL FORMATION AND BUSINESS DEVELOPMENT NEEDS OF HUNDREDS OF SMALL, INNOVATIVE COMPANIES THAT FORM THE BASIS OF THE BIOTECHNOLOGY INDUSTRY. THESE PROGRAMS FACILITATE CRITICAL CAPITAL FORMATION AND PARTNERSHIPS, AND PROVIDE PROFESSIONAL SERVICES. THROUGHOUT THE YEAR, BIO HOSTS OR CO-HOSTS 9 NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. THESE 2011 CONFERENCES SERVED MORE THAN 12,000 MEMBER AND NON-MEMBER ATTENDEES, AND INCLUDED MORE THAN 30,000 PARTNERING MEETINGS AND 950 COMPANY PRESENTATIONS OVER 10 DAYS OF OFFICIAL PROGRAMMING. THE 2011 U.S. PROGRAM INCLUDED: - BIO CEO & INVESTOR CONFERENCE, NEW YORK CITY, NY- BIO-WINDHOVER, NEW YORK CITY, NY, - BUSINESS FORUM AT THE BIO INTERNATIONAL CONVENTION, WASHINGTON, D.C.- BIO GLOBAL HEALTH CONFERENCE, WASHINGTON, D.C.- BIO INVESTOR FORUM, SAN FRANCISCO, CABIO ALSO ORGANIZES, HOSTS, OR ASSISTS WITH HOSTING, FIVE OF THE LARGEST BIOTECH MEETINGS OUTSIDE OF THE U.S.; THE 2011 THE PROGRAM INCLUDED:- BIO-ASIA, TOKYO, JAPAN- BIO-EUROPE SPRING- BIO INDIA, HYDERABAD, INDIA, - BIO CHINA, CHINA- BIO-EUROPE FALL, MUNICH, GERMANYIN ADDITION, IN 2011, BIO PROVIDED COST-EFFECTIVE EDUCATIONAL PROGRAMS TO HELP EXECUTIVES FROM SMALL COMPANIES. THESE WORKSHOPS, FOCUSED ON EXECUTIVE PRESENTATION SKILLS AND BASIC AND ADVANCED BUSINESS DEVELOPMENT SKILLS, WERE HELD THROUGHOUT THE YEAR IN VARIOUS LOCATIONS AROUND THE U.S. AND GERMANY.Description
FieldValueIRS element (for citing)
Described In501 C30DescribedIn501C3
Schedule B Required0ScheduleBRequired
Political Activities1PoliticalActivities
Subject To Proxy Tax1SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote0ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations0GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity0RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With1096180NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Number Of Employees184NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income1UnrelatedBusinessIncome
Form990-T Filed1Form990-TFiled
Foreign Financial Account1ForeignFinancialAccount
Name Of Foreign CountryINNameOfForeignCountry
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members116NbrVotingGoverningBodyMembers
Number Independent Voting Members116NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders1MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1JOANNE M DUNCANBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number2029629200TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW STE 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (134 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationOfficerOfficerKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
ATWOOD BRIAN
MEMBER2.00X000
BEALL ROBERT
MEMBER2.00X000
BEEMAN DONALD
MEMBER2.00X000
BEER MARC
MEMBER2.00X000
BERVEN DOUG
MEMBER2.00X000
BIENAIME JEAN-JACQUES
MEMBER2.00X000
BOGER JOSHUA
MEMBER2.00X000
BORISY ALEXIS
MEMBER2.00X000
BORMANN BJ
MEMBER2.00X000
CLARK IAN
MEMBER2.00X000
COHEN BRUCE
MEMBER2.00X000
COHEN RON
MEMBER2.00X000
COLES N
MEMBER2.00X000
CONWAY ROBERT
MEMBER2.00X000
CROWLEY JOHN
MEMBER2.00X000
DE RUITER TJERK
MEMBER2.00X000
DEBETHIZY J DONALD
MEMBER2.00X000
DOERFLER DOUGLAS
MEMBER2.00X000
DUNCAN GREG
MEMBER2.00X000
DUNSIRE DEBORAH
MEMBER2.00X000
EGGERT CHARLES
MEMBER2.00X000
ELLERBUSCH SUSAN
MEMBER2.00X000
ENO RICHARD
MEMBER2.00X000
FERGUSON BRUCE
MEMBER2.00X000
FISCHER PAUL
MEMBER2.00X000
FLINT JERRY
MEMBER2.00X000
FRITZ CAROLYN
MEMBER2.00X000
GATTO STEPHEN
MEMBER2.00X000
GERBERDING JULIE
MEMBER2.00X000
GERMANO GENO
MEMBER2.00X000
GIOVANNETTI GLEN
MEMBER2.00X000
GOLD MITCHELL
MEMBER2.00X000
GORMLEY GLENN
MEMBER2.00X000
GOWEN MAXINE
MEMBER2.00X000
GREENLEAF PETER
MEMBER2.00X000
GRUBER PATRICK
MEMBER2.00X000
GUTTERSON NEAL
MEMBER2.00X000
HALE DAVID
MEMBER2.00X000
HA-NGOC TUAN
MEMBER2.00X000
HASTINGS PAUL
MEMBER2.00X000
HATFIELD JEFFERY
MEMBER2.00X000
HERNDON RUSSELL
MEMBER2.00X000
HOLTZMAN STEVEN
MEMBER2.00X000
HOPPENOT HERVE
MEMBER2.00X000
HOYES JAMES
MEMBER2.00X000
HUTTNER JACK
MEMBER2.00X000
JUNIUS DANIEL
MEMBER2.00X000
KARSEN PERRY
MEMBER2.00X000
KING RACHEL
MEMBER2.00X000
KOENIG SCOTT
MEMBER2.00X000
KOSACZ BARBARA
MEMBER2.00X000
KREMER MATTHIAS
MEMBER2.00X000
KU KATHERINE
MEMBER2.00X000
LEAHY EMER
MEMBER2.00X000
LEFF JONATHAN
MEMBER2.00X000
LEONARD JOHN
MEMBER2.00X000
LESCHLY NICK
MEMBER2.00X000
LEVINE JAMES
MEMBER2.00X000
LUNDBERG JAN
MEMBER2.00X000
MANUSO JAMES
MEMBER2.00X000
MARAGANORE JOHN
MEMBER2.00X000
MATHERS EDWARD
MEMBER2.00X000
MATHERS THOMAS
MEMBER2.00X000
MCCAULEY GORDON
MEMBER2.00X000
MCHUGH JULIE
MEMBER2.00X000
MEDFORD RUSSELL
MEMBER2.00X000
MEEKER DAVID
MEMBER2.00X000
MENTO STEVEN
MEMBER2.00X000
MILANO VINCENT
MEMBER2.00X000
MILLIGAN JOHN
MEMBER2.00X000
MOCH KENNETH
MEMBER2.00X000
MONROE ADAM
MEMBER2.00X000
MYERS DAN
MEMBER2.00X000
NICOLAIDES NICHOLAS
MEMBER2.00X000
ORWIN JOHN
MEMBER2.00X000
OSTROVE JEFFERY
MEMBER2.00X000
PARKINSON ROBERT
MEMBER2.00X000
PELTZ STUART
MEMBER2.00X000
PERKINS ADELENE
MEMBER2.00X000
PETERSON KRISTINE
MEMBER2.00X000
POPS RICHARD
MEMBER2.00X000
PRUZANSKI MARK
MEMBER2.00X000
PYOTT DAVID
MEMBER2.00X000
READNOUR ROBIN
MEMBER2.00X000
ROBIN HOWARD
MEMBER2.00X000
RODELL TIMOTHY
MEMBER2.00X000
RYDER STEVEN
MEMBER2.00X000
SANDS ARTHUR
MEMBER2.00X000
SCHMIDT RALF-MICHAEL
MEMBER2.00X000
SHAW ALAN
MEMBER2.00X000
SHERWIN STEPHEN
MEMBER2.00X000
SHURDUT BRADLEY
MEMBER2.00X000
SIEGEL JAY
MEMBER2.00X000
STANDLEE CHRISTOPHER
MEMBER2.00X000
STEINER GERALD
MEMBER2.00X000
STOTISH RONALD
MEMBER2.00X000
STRAHLMAN ELLEN
MEMBER2.00X000
SULLIVAN EDDIE
MEMBER2.00X000
TANDA STEPHAN
MEMBER2.00X000
TASSE DANIEL
MEMBER2.00X000
THAKRAR ATUL
MEMBER2.00X000
TURCK ROLAND
MEMBER2.00X000
TUTTLE STEVEN
MEMBER2.00X000
VAN BOKKENLEN GIL
MEMBER2.00X000
VAN WART HAROLD
MEMBER2.00X000
VERBRUGGEN MARC
MEMBER2.00X000
WALBERT TIMOTHY
MEMBER2.00X000
WELLS BARBARA
MEMBER2.00X000
WOLFSON JONATHAN
MEMBER2.00X000
WONG MARK
MEMBER2.00X000
WYSE ROGER
MEMBER2.00X000
XANTHOPOULO KLEANTHIS
MEMBER2.00X000
ZAKES BRADFORD
MEMBER2.00X000
ZERBE ROBERT
MEMBER2.00X000
BONANNI FABRIZIO
SECRETARY2.00X000X
SKALETSKY MARK
TREASURER2.00X000X
WATKINS H THOMAS
BOARD CHAIR2.00X000X
GREENWOOD JAMES
CEO & PRESIDENT50.0023678750102549X
MURPHY EARLY LISA
SR VP, FINANCE & ADMIN & CFO50.00289629010271X
JOANNE DUNCAN
CFO & VP, FINANCE & ADMIN50.003436901850X
WHITAKER A SCOTT
COO50.00710480053478X
DILENGE THOMAS
GENERAL COUNSEL50.00380970053769X
EISENBERG ALAN
EXEC VP, EMERGING COMPANIES SECTION & BUSINESS DEV50.00392298054776X
DEL MONTE BRENT
VP, FEDERAL GOVERNMENT RELATIONS50.00355037043862X
ERICKSON BRENT
EXEC VP, INDUSTRIAL & ENVIRONMENTAL SECTION50.00392546051522X
JOSEPH JEFFREY
VP, COMMUNICATIONS50.00307255050489X
FINAN AMY
VP, CORPORATE DEVELOPMENT & MARKETING50.00346142044514X
LYCETT ROBERTA
VP, CONVENTIONS & CONFERENCES50.00264984049110X
RADCLIFFE SARA
EXEC VP, HEALTH POLICY SECTION50.00437828044017X
DARRAGH SEAN
EXECUTIVE VICE PRESIDENT, INTERNATIONAL AFFAIRS50.00261029017296X
DENNIS SANDRA
DEPUTY GENERAL COUNSEL, HEALTHCARE REG AFFAIRS50.00279312045995X
SAUER HANSJORG
DEPUTY GENERAL COUNSEL, INTELLECTUAL PROPERTY50.00270005044041X
MCHUGH PETER
COMPLIANCE OFFICER, DEPUTY GENERAL COUNSEL50.00234496044861X
FEISEE LILA
VP, INTERNATIONAL AFFAIRS50.00255566053051X
FieldValueIRS element (for citing)
Total Reportable Comp From Org7579821TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation765451TotalOtherCompensation
Number Individuals GT100 K67NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
FREEMAN COMPANIES
1600 VICEROY SUITE 100DALLASTX75247GENERAL CONTRACTOR: CONV/CONFERENCES1324777
PROJECTION INC
PO BOX 890472CHARLOTTENC28289VIDEO SERVICES: CONV/CONFERENCES875577
VOLUME SERVICES AMERICA
111 WEST HARBOR DRSAN DIEGOCA92101CATERING SERVICES: INTN'L CONV836267
RHODE PLANNING & MGMT SOLUTIONS
42 LADD ST SUITE 302EAST GREENWICHRI02818TRANSPORTATION SERVICES: INTN'L CONV818268
FIXATION MARKETING
4340 EAST-WEST HWY SUITE 200BETHESDAMD208144411MARKETING: INTN'L CONVENTION661363
FieldValueIRS element (for citing)
Number Of Contractors GT100 K78NumberOfContractorsGT100K

Program Service Revenue ProgramServiceRevenue (4 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncomeUnrelated Business RevenueUnrelatedBusinessRevenueExclusionExclusionAmount
CONFERENCE/MEETING REV5418003348858933221422267167
MEMBERSHIP DUES9000992217380722173807
BUSINESS SOLUTIONS9000993555215$3,555,215
PUBLICATION ADVERTISIN5418006658540666179
FieldValueIRS element (for citing)
Total Program Service Revenue59284196TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column1563571TotalRevenueColumn
Exclusion$1,563,571ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities16271475Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities15840514Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities430961Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column430961TotalRevenueColumn
Exclusion$430,961ExclusionAmount

Other Revenue Misc OtherRevenueMisc

FieldValueIRS element (for citing)
DescriptionINTERNET REVENUESDescription
Business Code900099BusinessCode
Total Revenue Column3900TotalRevenueColumn
Related Or Exempt Function Income3900RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Other Revenue3900TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column61282628TotalRevenueColumn
Related Or Exempt Function Income55399535RelatedOrExemptFunctionIncome
Unrelated Business Revenue333346UnrelatedBusinessRevenue
Exclusion$5,549,747ExclusionAmount

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total5956466Total

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total14267376Total

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total2067918Total

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total1997099Total

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total1022170Total

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total348999Total

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total70951Total

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total3147612Total

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total261808Total

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total4586188Total

Advertising Advertising

FieldValueIRS element (for citing)
Total230217Total

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total1865342Total

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total822172Total

Occupancy Occupancy

FieldValueIRS element (for citing)
Total3699419Total

Travel Travel

FieldValueIRS element (for citing)
Total895308Total

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total16635286Total

Interest Interest

FieldValueIRS element (for citing)
Total2949Total

Payments To Affiliates PaymentsToAffiliates

FieldValueIRS element (for citing)
Total1155732Total

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total1179139Total

Insurance Insurance

FieldValueIRS element (for citing)
Total103370Total

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotal
OUTREACH513037
TAXES PAID75547
EDUCATION42957
BAD DEBT EXPENSE14360

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total60961422Total

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY6979800BOY
EOY4459681EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY1805535BOY
EOY2602547EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY2907323BOY
EOY2383665EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis11797165LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec7764303LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY4852112BOY
EOY4032862EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY48535212BOY
EOY52118530EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY334031BOY
EOY260352EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY65414013BOY
EOY65857637EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY8055493BOY
EOY8591779EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY12037740BOY
EOY13043071EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY6371762BOY
EOY6142417EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY26464995BOY
EOY27777267EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY38949018BOY
EOY38080370EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY38949018BOY
EOY38080370EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY65414013BOY
EOY65857637EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses321206ReconcilationRevenueExpenses
Reconcilation Other Changes-1189854ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement SeparateXFinancialStatementSeparate
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Political Expenditures2500PoliticalExpenditures
Amt Of Internal Funds Contributed2500AmtOfInternalFundsContributed
Total Exmpt Function Expenditures2500TotalExmptFunctionExpenditures
Form1120 Pol Filed1Form1120PolFiled

Sec527 Pol Orgs Sec527PolOrgs

Name Of527 Organization NameOf527Organization

FieldValueIRS element (for citing)
Business Name Line1FRIENDS OF SUSANA MENDOZABusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12646 S SAWYER AVENUEAddressLine1
CityCHICAGOCity
StateILState
ZIP Code60623ZIPCode
FieldValueIRS element (for citing)
EIN870732736EIN
Amt Pd From Internal Funds2500AmtPdFromInternalFunds
FieldValueIRS element (for citing)
Substantially All Dues Nondeduct0SubstantiallyAllDuesNondeduct
Only In House Lobbying0OnlyInHouseLobbying
Agree To Carryover Prior Year1AgreeToCarryoverPriorYear
Dues Assessments22173807DuesAssessments
Non Ded Lobby Political Current7990000NonDedLobbyPoliticalCurrent
Non Ded Lobby Political Carryover14386NonDedLobbyPoliticalCarryover
Non Ded Lobby Political Total8004386NonDedLobbyPoliticalTotal
Aggr Amt Reported In Dues Notices7983000AggrAmtReportedInDuesNotices
Amount To Be Carried Over21386AmountToBeCarriedOver

Form990 Schedule C Part IV Form990ScheduleCPartIV

FieldValueIRS element (for citing)
IdentifierORGANIZATIONS DIRECT AND INDIRECT POLITICAL CAMPAIGN ACTIVITIES:Identifier
Return ReferencePART I-A, LINE 1:ReturnReference
ExplanationPOLITICAL CAMPAIGN CONTRIBUTIONExplanation

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovements

FieldValueIRS element (for citing)
Other Cost Or Other Basis7882920OtherCostOrOtherBasis
Depreciation4567950Depreciation
Book Value3314970BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis3914245OtherCostOrOtherBasis
Depreciation3196353Depreciation
Book Value717892BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings4032862TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities (2 entries)

DescriptionDescriptionAmountAmount
CAPITAL LEASE OBLIGATION$182,799
DEFERRED RENT$5,959,618
FieldValueIRS element (for citing)
Total Of Amounts6142417TotalOfAmounts
Total Revenue61282628TotalRevenue
Total Expenses60961422TotalExpenses
Excess Or Deficit For Year321206ExcessOrDeficitForYear
Net Unrealized GL On Investments-1204082NetUnrealizedGLOnInvestments
Other$14,228OtherAmount
Total Adjustments-1189854TotalAdjustments
Excess Or Deficit Per FS-868648ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt62540294TotRevenueEtcAuditedFinclStmt
Other Revenues1519474OtherRevenues
Revenue Not Rptd F9901519474RevenueNotRptdF990
Revenue Subtotal61020820RevenueSubtotal
Investment Expenses Not Included261808InvestmentExpensesNotIncluded
Revenue Not Rptd On Fin Stmt261808RevenueNotRptdOnFinStmt
Total Revenue Per Form99061282628TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt62204860TotExpensesEtcAuditedFinclStmt
Other Expenses Included1505246OtherExpensesIncluded
Expenses Not Rptd F9901505246ExpensesNotRptdF990
Expenses Subtotal60699614ExpensesSubtotal
Investment Expenses Not Included2261808InvestmentExpensesNotIncluded2
Expenses Not Rptd On Fin Stmt261808ExpensesNotRptdOnFinStmt
Total Expenses Per Form99060961422TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)

IdentifierIdentifierExplanationExplanation
PART XI, LINE 8 - OTHER ADJUSTMENTS:CBI REVENUE 31,741. CBI LOBBYING FUND REVENUE 442,576. FOOD & AG INITIATIVES REVENUE 128,507. FOOD & AG INITIATIVES EXPENSES -132,791. CBI LOBBYING FUND EXPENSE -455,805. TOTAL TO SCHEDULE D, PART XI, LINE 8: 14,228.
PART XII, LINE 2D - OTHER ADJUSTMENTS:CBI 31,741. CBI LOBBYING FUND 442,576. FOOD & AG INITIATIVES REVENUE 128,507. MEDICARE EXPENSES 916,650.
PART XIII, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG INITIATIVES EXPENSES 132,791. CBI LOBBYING FUND 455,805. MEDICARE EXPENSES 916,650.
PART X, LINE 2: THE ORGANIZATION ADOPTED THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS IN 2010. THE ORGANIZATION HAS EVALUATED ITS TAX POSITIONS FOR 2011 AND DETERMINED THAT ITS TAX POSITIONS ARE MORE-LIKELY-THAN-NOT TO BE SUSTAINED ON EXAMINATION. AS SUCH, THE 2011 FINANCIAL STATEMENTS ARE NOT REQUIRED AND THEREFORE DO NOT CONTAIN A FOOTNOTE RELATED TO UNCERTAIN TAX POSITIONS.

Schedule F IRS990ScheduleF

Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EUROPE01PROGRAM SERVICESCONFERENCE124582
SOUTH ASIA03PROGRAM SERVICESCONFERENCE293466
EAST ASIA AND THE PACIFIC02PROGRAM SERVICESCONFERENCE1798757
NORTH AMERICA00PROGRAM SERVICESCONFERENCE921260
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees6SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees6TotalNumberOfEmployees
Subtotal Amount Spent3138065SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent3138065TotalAmountSpent
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelXFirstClassOrCharterTravel
Travel For CompanionsXTravelForCompanions
Club Dues Or FeesXClubDuesOrFees
Written Policy Re T And E Expenses1WrittenPolicyReTAndEExpenses
Substantiation Required1SubstantiationRequired
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan1SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement

Form990 Schedule J Part II Form990ScheduleJPartII (16 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
GREENWOOD JAMES
100016803492000101850702870207384702470424010185070
MURPHY EARLY LISA
17843401111950001923083480299900000
WHITAKER A SCOTT
5529800157500000287020247760763958000
DILENGE THOMAS
38097000000287020250670434739000
EISENBERG ALAN
39229800000287020260740447074000
DEL MONTE BRENT
35503700000287020151600398899000
ERICKSON BRENT
327546065000000287020228200444068000
JOSEPH JEFFREY
30725500000250270254620357744000
FINAN AMY
268142078000000285860159280390656000
LYCETT ROBERTA
26498400000287020204080314094000
RADCLIFFE SARA
340328097500000287020153150481845000
DARRAGH SEAN
16652909450000020480152480278325000
DENNIS SANDRA
267812011500000287020172930325307000
SAUER HANSJORG
250505019500000267480172930314046000
MCHUGH PETER
214996019500000275790172820279357000
FEISEE LILA
223350032216000283670246840308617000

Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)

Return ReferenceReturnReferenceExplanationExplanation
PART I, LINE 1AJAMES GREENWOOD - FIRST CLASS TRAVEL - $13,619 - TRAVEL FOR COMPANIONS - $1,392 - HEALTH/SOCIAL CLUB DUES - $4,125 ALAN EISENBERG - HEALTH/SOCIAL CLUB DUES - $780 THE ABOVE ITEMS WERE NOT INCLUDED IN THE TAXABLE INCOME OF THE INDIVIDUAL.
PART I, LINE 4BJAMES GREENWOOD 457(F) PLAN $1,018,507

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (9 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 2BASED ON RESPONSES TO A SURVEY DISTRIBUTED TO EACH MEMBER OF BIOS BOARD OF DIRECTORS, TWO MEMBERS - MAXINE GOWEN AND VINCENT MILANO - DISCLOSED A BUSINESS RELATIONSHIP WITH ANOTHER MEMBER OF THE BIO BOARD DURING 2011. IN BOTH CASES, THE BUSINESS RELATIONSHIP WAS IDENTIFIED AS A DIRECTOR BEING ON THE BOARD OF ANOTHER BIO MEMBER COMPANY THAT IS REPRESENTED ON BIOS BOARD.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS. ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS. ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AFOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CFO. THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, COO, CFO AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD FOR REVIEW, QUESTIONS AND/OR COMMENTS, AND THEN SENT TO THE BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS AS WELL. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIO TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15IN 2011, THE EXECUTIVE AGREEMENT FOR THE PRESIDENT AND CEO OF BIO WAS RENEGOTIATED AND RENEWED, IN A PROCESS THAT WAS LED BY THE CHAIRMAN OF THE BOARD, IN CONSULTATION WITH EXTERNAL INDEPENDENT LEGAL AND COMPENSATION CONSULTANTS AND WITH THE FULL BOARD OF DIRECTORS, AND FINAL APPROVAL BY THE BIO EXECUTIVE COMMITTEE OF THE BOARD. IN 2011, THE BIO EXECUTIVE COMMITTEE ALSO EVALUATED THE PERFORMANCE OF THE BIO PRESIDENT AND CEO UNDER HIS PRIOR EXECUTIVE AGREEMENT, AND BASED ON THIS PERFORMANCE EVALUATION, DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR. THE COMPENSATION HE RECEIVED IS DETAILED THROUGH THIS EXECUTIVE AGREEMENT. THE BIO EXECUTIVE COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BIO BOARD MEMBERS, LEADS AND UNDERTAKES THIS ANNUAL PROCESS. IN CARRYING OUT BOTH FUNCTIONS, THE MEMBERS OF THE EXECUTIVE COMMITTEE ARE ASSISTED AND COUNSELED, CONTEMPORANEOUSLY, BY BOTH INDEPENDENT OUTSIDE LEGAL COUNSEL WHO IS AN EXPERT IN THIS AREA OF THE LAW, AND AN INDEPENDENT OUTSIDE CONSULTANT THAT PROVIDED BENCHMARKING SERVICES AND INFORMATION ON EXECUTIVE COMPENSATION ISSUES. FORM 990, PART VI, SECTION B, LINE 15B: DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER LEADS AND UNDERTAKES THIS PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART XI, LINE 5:NET UNREALIZED LOSSES ON INVESTMENTS: -1,204,082. CBI REVENUE 31,741. CBI LOBBYING FUND REVENUE 442,576. FOOD & AG INITIATIVES REVENUE 128,507. FOOD & AG INITIATIVES EXPENSES -132,791. CBI LOBBYING FUND EXPENSE -455,805. TOTAL TO FORM 990, PART XI, LINE 5: -1,189,854.CHANGES IN NET ASSETS OR FUND BALANCES:

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.